184 related articles for article (PubMed ID: 20884263)
1. Docking to flexible nicotinic acetylcholine receptors: a validation study using the acetylcholine binding protein.
Sander T; Bruun AT; Balle T
J Mol Graph Model; 2010 Nov; 29(3):415-24. PubMed ID: 20884263
[TBL] [Abstract][Full Text] [Related]
2. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
Xiao Y; Hammond PS; Mazurov AA; Yohannes D
J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
[TBL] [Abstract][Full Text] [Related]
3. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
[TBL] [Abstract][Full Text] [Related]
4. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
Brejc K; van Dijk WJ; Smit AB; Sixma TK
Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
[TBL] [Abstract][Full Text] [Related]
5. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
[TBL] [Abstract][Full Text] [Related]
7. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors.
Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI
Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029
[TBL] [Abstract][Full Text] [Related]
8. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
[TBL] [Abstract][Full Text] [Related]
9. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
[TBL] [Abstract][Full Text] [Related]
11. Insight in nAChR subtype selectivity from AChBP crystal structures.
Rucktooa P; Smit AB; Sixma TK
Biochem Pharmacol; 2009 Oct; 78(7):777-87. PubMed ID: 19576182
[TBL] [Abstract][Full Text] [Related]
12. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
Yuan H; Petukhov PA
Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
[TBL] [Abstract][Full Text] [Related]
13. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Hansen SB; Taylor P
J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
[TBL] [Abstract][Full Text] [Related]
14. Structural dynamics of the alpha-neurotoxin-acetylcholine-binding protein complex: hydrodynamic and fluorescence anisotropy decay analyses.
Hibbs RE; Johnson DA; Shi J; Hansen SB; Taylor P
Biochemistry; 2005 Dec; 44(50):16602-11. PubMed ID: 16342951
[TBL] [Abstract][Full Text] [Related]
15. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
16. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
Dutertre S; Nicke A; Tyndall JD; Lewis RJ
J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
[TBL] [Abstract][Full Text] [Related]
17. Docking of alpha-cobratoxin suggests a basal conformation of the nicotinic receptor.
Konstantakaki M; Changeux JP; Taly A
Biochem Biophys Res Commun; 2007 Aug; 359(3):413-8. PubMed ID: 17555709
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding the structure of nicotinic acetylcholine receptors.
Zouridakis M; Zisimopoulou P; Poulas K; Tzartos SJ
IUBMB Life; 2009 Apr; 61(4):407-23. PubMed ID: 19319967
[TBL] [Abstract][Full Text] [Related]
19. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Huang SY; Zou X
Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
[TBL] [Abstract][Full Text] [Related]
20. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M
Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
